Neuroprotection: Still achievable in humans

Stroke

Volumn 39, Issue 2, 2008, Pages 525-

  Donnan, Geoffrey A ^a   Davis, Stephen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Neuroprotection

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; NEUROPROTECTIVE AGENT;

ARTICLE; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG POTENCY; HUMAN; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPERFUSION; STROKE; NOTE;

BRAIN ISCHEMIA; HUMANS; NEUROPROTECTIVE AGENTS; STROKE;

EID: 39349094984     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.494807     Document Type: Article

References (7)

1. Davis SM, Donnan GA. Neuroprotection: Establishing proof of concept in human stroke. Stroke. 2002;33:309-310.
2. Fisher M, Hanley DF, Howard G, Jauch EC, Warach S. Recommendations from the stair v meeting on acute stroke trials, technology and outcomes. Stroke. 2007;38:245-248.
3. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW. NXY-059 for acute ischemic stroke. N Engl J Med. 2006;354:588-600.
4. Shuaib A LK, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski W, Emeribe U. Nxy-059 for acute ischemic stroke; results of the saint ii trial. Nejm in press. N Engl J Med. In Press.
5. Davalos A, Castillo J, Serena J, Noya M. Duration of glutamate release after acute ischemic stroke. Stroke. 1997;28:708-710.
6. Donnan G. William M. Feinberg award for excellence in clinical stroke 2007. A new roadmap for neuroprotection. American Stroke Conference 2007.
7. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: Results of the field administration of stroke therapy-magnesium (fast-mag) pilot trial. Stroke. 2004;35:e106-e108.